Cannabist Co Holdings Inc. Enters Material Definitive Agreement
Ticker: CBSTF · Form: 8-K · Filed: Oct 4, 2024 · CIK: 1776738
| Field | Detail |
|---|---|
| Company | Cannabist Co Holdings Inc. (CBSTF) |
| Form Type | 8-K |
| Filed Date | Oct 4, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $10 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, corporate-action
TL;DR
Cannabist Co Holdings Inc. just signed a big deal on 9/30/24.
AI Summary
On September 30, 2024, The Cannabist Company Holdings Inc. entered into a material definitive agreement. The company, formerly known as Columbia Care Inc., is incorporated in British Columbia and has its principal executive offices in New York, NY.
Why It Matters
This filing indicates a significant new contract or partnership for Cannabist Co Holdings Inc., which could impact its future operations and financial performance.
Risk Assessment
Risk Level: medium — Entering into material definitive agreements can introduce new risks related to contract fulfillment, financial obligations, or strategic alignment.
Key Numbers
- 000-56294 — SEC File Number (Identifies the company's filing with the SEC)
- 98-1488978 — IRS Employer Identification No. (Company's tax identification number)
Key Players & Entities
- The Cannabist Company Holdings Inc. (company) — Registrant
- Columbia Care Inc. (company) — Former company name
- September 30, 2024 (date) — Date of earliest event reported
- 2024-09-30 (date) — Conformed period of report
- 20241004 (date) — Filing date
FAQ
What is the nature of the material definitive agreement entered into by Cannabist Co Holdings Inc. on September 30, 2024?
The filing does not specify the details of the material definitive agreement, only that one was entered into on September 30, 2024.
What was the former name of The Cannabist Company Holdings Inc.?
The former name of The Cannabist Company Holdings Inc. was Columbia Care Inc.
In which jurisdiction is The Cannabist Company Holdings Inc. incorporated?
The Cannabist Company Holdings Inc. is incorporated in British Columbia.
What is the principal executive office address for The Cannabist Company Holdings Inc.?
The principal executive offices are located at 680 Fifth Ave., 24th Floor, New York, New York, 10019.
When was the Form 8-K filed?
The Form 8-K was filed on October 4, 2024.
Filing Stats: 515 words · 2 min read · ~2 pages · Grade level 12.1 · Accepted 2024-10-04 16:14:00
Key Financial Figures
- $10 million — transfer an aggregate of approximately $10 million principal amount of Notes in considerat
Filing Documents
- d808171d8k.htm (8-K) — 20KB
- 0001193125-24-233058.txt ( ) — 131KB
- ck0001776738-20240930.xsd (EX-101.SCH) — 2KB
- ck0001776738-20240930_lab.xml (EX-101.LAB) — 16KB
- ck0001776738-20240930_pre.xml (EX-101.PRE) — 10KB
- d808171d8k_htm.xml (XML) — 3KB
From the Filing
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): September 30, 2024 THE CANNABIST COMPANY HOLDINGS INC. (Exact Name of Registrant as specified in its charter) British Columbia 000-56294 98-1488978 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 680 Fifth Ave. , 24th Floor New York , New York 10019 (Address of principal executive offices) (Zip Code) ( 212 ) 634-7100 (Registrant's telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: None. Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging Growth Company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. Item1.01. Entry into a Material Definitive Agreement. On September 30, 2024, The Cannabist Company Holdings Inc. (the "Company") entered into a second amendment (the "Amendment") to the exchange agreement (the "Exchange Agreement"), dated January 22, 2024, as amended on June 30, 2024, with certain holders (the "Holders") of the Company's 6.0% senior secured convertible notes due June 2025 (the "Notes"), pursuant to which the parties agreed to extend the period in which the Holders may transfer an aggregate of approximately $10 million principal amount of Notes in consideration of common shares of the Company to December 31, 2024. The parties also agreed to extend the term of the Exchange Agreement to January 31, 2025. Item 1.01 of this Current Report on Form 8-K contains only a brief description of the material terms of and does not purport to be a complete description of the rights and obligations of the parties to the Amendment, and such description is qualified in its entirety by reference to the full text of the Amendment, which will be filed with the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2024. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. THE CANNABIST COMPANY HOLDINGS INC. By: /s/ David Sirolly Name: David Sirolly Title: Chief Legal Officer & General Counsel Date: October 4, 2024